Company intelligence / Profile preview

Weiss

Ascheberg, North Rhine-Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

WeissBioTech is a German industrial biotechnology company focused on tailored ready-to-use enzyme formulations for food and beverage processing rather than human therapeutics. Its products have been used in applications including wine, beer, fruit juice, sugar, starch, potable alcohol, and bioethanol processing. The company operated from Ascheberg, Germany and was acquired in November 2023 as part of Biocatalysts' expansion of the BRAIN Biotech group's BioProducts division. WeissBioTech continues to exist operationally as part of Biocatalysts' beverages and grain processing activities. It is not a life science drug developer, pharma company, or healthcare services business.

Modalities: ProteinEnzyme
Industry: Non-Drug Biotech

Partnerships

BiocatalystsBRAIN Biotech

Beyond the preview

Go deeper on Weiss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weiss.

Explore the full profile